B
AFRICA RESOURCE CENTER FOR EXCELLENCE IN SUPPLY CHAIN MANAGEMENT (ARC_ESM)
ARC_ESM was established as an independent advisor and strategic partner to provide support to Ministries of Health, Agencies, Donors and Partners. The Center has adopted a theory of change that outlines a vision to complement other actors to accelerate and sustain improvement in key supply chain outcomes. www.africaresourcecentre.org
C
AMREF HEALTH AFRICA
Amref Health Africa is the largest Africa-based international health development organisation; currently implementing more than 170 programs, directly reaching more than 7 million people and 30 million indirectly across 35 African countries (in 2020 alone). Headquartered in Nairobi, Kenya, Amref Health Africa has offices in seven country offices in Africa, including Kenya, Tanzania, Uganda, Ethiopia, Malawi, South Sudan, Zambia, Senegal. An additional eleven advocacy and fundraising offices are located in Europe and North America. Amref Health Africa’s vision is that of ‘Lasting health change in Africa’, with a mission to increase sustainable health access to communities in Africa through solutions in human resources for health, health service delivery, and investments in health. www.amref.org
D
@GRVGLOBAL | #PLA2021
ROUNDTABLE PROFILES
15
ASPEN PHARMACARE HOLDINGS LTD
With a 160-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets with approximately 10 000 employees at 70 established business operations in 55 countries. We improve the health of patients in more than 150 countries through our high quality, affordable products. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products. www.aspenpharma.com
E
BOTSWANA MEDICINES REGULATORY AUTHORITY
WWW.GRVGLOBAL.COM
The Medicines Regulatory Authority is a corporate body, established by the Parliament of Botswana, under Section 3 of the Medicines and Related Substances Act (“MRSA”) and commonly referred to as the Botswana Medicines Regulatory Authority or BoMRA. BoMRA commenced operations in January 2018, with the mandate of ensuring the safety, efficacy and quality of medicines and related substances, which includes human and veterinary medicines, medical devices and cosmetics in Botswana. BoMRA regulates the supply chain of medicines, medical devices and cosmetics through registration of products, licensing of entities dealing in such products and pharmacovigilance activities to monitor products once in the market. In late 2018, it adopted its maiden 5 - year strategy with one of its key targets being to reach Maturity Level three (ML3), as evaluated against the World Health Organisation Global Benchmarking Tool. www.bomra.co.bw
